The Centers for Innovation in Advanced Development and Manufacturing had difficulty reliably producing larger drug product amounts.
GAO to HHS: Learn from COVID mistakes in replacing drug-manufacturing program
More from COVID-19More posts in COVID-19 »
- COVID-19 linked to increased preterm birth, other problems in pregnancy
- COVID, other misinformation varies by topic, country on social media
- Quick takes: Cholera vaccine shortages, pre-exposure COVID prevention, HPV screening specimen self-collection
- Study: Before vaccines, 44% of COVID-19 patients in ICU died